November 19, 2013
Why Rare Diseases are Big Pharma’s Latest Obsession
Read More
November 14, 2013
Shire to Pay $4.2 Billion for Rare Disease Firm ViroPharma
Read More
October 22, 2012
Health Canada Approves New Drug Submission for CINRYZE™ (C1 Inhibitor [Human])
Read More
X